New England Research & Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Sell |
445
-400
| -47% | -$215K | 0.11% | 140 |
|
|
2025
Q1 | $355K | Sell |
845
-1,250
| -60% | -$525K | 0.18% | 120 |
|
|
2024
Q4 | $866K | Buy |
2,095
+715
| +52% | +$296K | 0.44% | 74 |
|
|
2024
Q3 | $697K | Buy |
1,380
+100
| +8% | +$50.5K | 0.33% | 92 |
|
|
2024
Q2 | $624K | Sell |
1,280
-75
| -6% | -$36.6K | 0.3% | 105 |
|
|
2024
Q1 | $732K | Sell |
1,355
-425
| -24% | -$230K | 0.36% | 95 |
|
|
2023
Q4 | $988K | Buy |
1,780
+305
| +21% | +$169K | 0.52% | 66 |
|
|
2023
Q3 | $645K | Buy |
+1,475
| New | +$645K | 0.37% | 90 |
|
|
2023
Q1 | – | Sell |
-1,075
| Closed | -$439K | – | 159 |
|
|
2022
Q4 | $439K | Sell |
1,075
-1,425
| -57% | -$582K | 0.25% | 116 |
|
|
2022
Q3 | $815K | Buy |
+2,500
| New | +$815K | 0.51% | 71 |
|
|
2022
Q2 | – | Sell |
-575
| Closed | -$315K | – | 166 |
|
|
2022
Q1 | $315K | Hold |
575
| – | – | 0.16% | 131 |
|
|
2021
Q4 | $379K | Hold |
575
| – | – | 0.18% | 129 |
|
|
2021
Q3 | $358K | Hold |
575
| – | – | 0.19% | 130 |
|
|
2021
Q2 | $363K | Hold |
575
| – | – | 0.19% | 131 |
|
|
2021
Q1 | $281K | Sell |
575
-25
| -4% | -$12.2K | 0.15% | 144 |
|
|
2020
Q4 | $300K | Hold |
600
| – | – | 0.19% | 135 |
|
|
2020
Q3 | $236K | Sell |
600
-450
| -43% | -$177K | 0.17% | 126 |
|
|
2020
Q2 | $347K | Hold |
1,050
| – | – | 0.25% | 115 |
|
|
2020
Q1 | $254K | Buy |
+1,050
| New | +$254K | 0.22% | 117 |
|
|
2019
Q1 | – | Sell |
-1,725
| Closed | -$321K | – | 172 |
|
|
2018
Q4 | $321K | Buy |
+1,725
| New | +$321K | 0.25% | 117 |
|
|
2016
Q1 | – | Sell |
-4,050
| Closed | -$295K | – | 168 |
|
|
2015
Q4 | $295K | Buy |
+4,050
| New | +$295K | 0.26% | 126 |
|
|
2014
Q4 | – | Sell |
-9,200
| Closed | -$542K | – | 180 |
|
|
2014
Q3 | $542K | Buy |
+9,200
| New | +$542K | 0.47% | 92 |
|